Xiaflex is the first nonsurgical option for the disorder. FDA sanctioned Auxilium Pharmaceuticals’ Xiaflex to treat Dupuytren contracture. The firm reports that the drug launch is planned for late ...
PALO ALTO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results